EARNEST Partners Updates Passive Stake in Pediatrix Medical Group
Ticker: MD · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 893949
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**EARNEST Partners still owns Pediatrix stock, showing continued institutional confidence.**
AI Summary
EARNEST Partners, LLC, a Delaware-based investment advisor, filed an amended Schedule 13G/A on February 12, 2024, indicating their ownership in Pediatrix Medical Group, Inc. (formerly MEDNAX, Inc.) as of December 31, 2023. This filing updates their previous disclosures, confirming their continued significant, but passive, stake in the healthcare services company. This matters to investors as it shows a large institutional investor maintains a position, which can be seen as a vote of confidence, but the specific percentage of ownership is not detailed in the provided text.
Why It Matters
This filing confirms a major institutional investor, EARNEST Partners, LLC, continues to hold shares in Pediatrix Medical Group, Inc., signaling ongoing institutional interest in the company.
Risk Assessment
Risk Level: low — This is a routine update from a passive investor and does not indicate any immediate risk or significant change in company control.
Analyst Insight
Investors should note that a significant institutional investor, EARNEST Partners, LLC, continues to hold a stake in Pediatrix Medical Group, Inc. This suggests ongoing institutional confidence, but the filing itself doesn't provide new information about the company's performance or future outlook. It's a routine update for a passive investment.
Key Numbers
- 0000893949 — Pediatrix Medical Group, Inc. CIK (unique identifier for the subject company)
- 0001102578 — EARNEST Partners, LLC CIK (unique identifier for the filing entity)
- 58502B106 — CUSIP Number (identifies the common stock of Pediatrix Medical Group, Inc.)
- 2 — Amendment Number (indicates this is the second amendment to the original Schedule 13G filing)
Key Players & Entities
- EARNEST Partners, LLC (company) — the reporting person and institutional investor
- Pediatrix Medical Group, Inc. (company) — the issuer of the securities
- MEDNAX, INC. (company) — former name of Pediatrix Medical Group, Inc.
- Delaware (company) — place of organization for EARNEST Partners, LLC
- February 12, 2024 (date) — date the SC 13G/A was filed
- December 31, 2023 (date) — date of the event requiring the filing
Forward-Looking Statements
- EARNEST Partners, LLC will maintain a passive investment strategy in Pediatrix Medical Group, Inc. (EARNEST Partners, LLC) — high confidence, target: Next 12 months
FAQ
What type of filing is this and who filed it?
This is an SC 13G/A (Amendment No. 2) filing, which is an amendment to a Schedule 13G. It was filed by EARNEST Partners, LLC regarding their ownership in Pediatrix Medical Group, Inc.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Pediatrix Medical Group, Inc. is 58502B106, as stated in the filing.
When was the event that required this filing?
The date of the event which required this filing was December 31, 2023, as indicated in the document.
What rule under the Securities Exchange Act of 1934 is this Schedule 13G filed under?
This Schedule 13G is filed under Rule 13d-1(b), as designated by the 'X' in the appropriate box within the filing.
What was the former name of Pediatrix Medical Group, Inc. and when did the name change occur?
Pediatrix Medical Group, Inc. was formerly known as MEDNAX, INC., with a name change date of 20090102 (January 2, 2009). It was also formerly known as PEDIATRIX MEDICAL GROUP INC, with a name change date of 19950801 (August 1, 1995).
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 12, 2024 regarding Pediatrix Medical Group, Inc. (MD).